Komori
Results6180GMO Media,Inc.Information and Communications, Services and Others

Summary of Financial Results for the Third Quarter of the Fiscal Year Ending December 2026 [Japanese GAAP] (Consolidated)

For the nine months ended the third quarter of the fiscal year ending December 2026, revenue decreased 8.0% year on year and operating profit decreased 41.5%, resulting in lower revenue and lower profit. The Company revised its full-year forecast based on recent business trends, while leaving its dividend forecast unchanged.

Worth reading
49Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Deterioration
Direction inferred from the company’s description.
Scale
41.5
% decrease (operating profit)
Wording
Conditional
How definitive the wording is.

Results for this period

Third quarter1 January 2026–30 September 2026ConsolidatedJapanese GAAP
Net Sales4,966¥ millionYear on year -8.0%Progress 75.8%
Operating profit469¥ millionYear on year -41.5%Progress 85.3%
Ordinary income477¥ millionYear on year -40.5%Progress 85.9%
Net income attributable to owners of the parent326¥ millionYear on year -44.8%Progress 86.9%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥181.54
Financial position at period-end
Total assets5,741¥ million
of which net assets 2,975 ¥ millionEquity ratio 51.4%vs. prior year-end +1.8pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Segment revenueMedia Business 4,601,219 thousand yen (YoY -5.0%), Solutions Business 365,162 thousand yen (YoY -33.9%)
Segment profitMedia Business 485,029 thousand yen (YoY -30.7%), Solutions Business -15,798 thousand yen
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥6,550 million (YoY -7.9%)
Operating profit¥550 million (YoY -38.9%)
Ordinary income¥555 million (YoY -38.1%)
Net income¥375 million (YoY -42.0%)
Revision to Earnings ForecastNot disclosed → Net Sales 6,550 / Operating profit 550 / Ordinary income 555 / Net income 375
Annual Dividend Forecast241 yen → 210 yen(-12.9%)
Factors Behind Changes in Business Performance

Lower web advertising rates, changes in traffic from search engines, and lower revenue due to intensifying competition in the medical aesthetics sector. In the Solutions business, the impact of large customers revising their contract terms and the increase in direct advertising placements by advertisers as the market matured. Recurring revenue in the industry-specific business increased 68.2% year on year.

Disclosure regarding the going concern assumption

No applicable matters

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 0 companies / Excluded 0 companies / Company name None
Breakdown of extraordinary income (loss)Current fiscal year No extraordinary gains or losses recorded
Depreciation and amortization72,654 thousand yen
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingYes (for analysts and institutional investors)
Issued Shares at Period-End1,868,839 shares
Treasury Shares at Period-End81,032 shares
Results for this period
ItemDetails
Fiscal Period ClassificationThird quarter
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered1 January 2026–30 September 2026
Net Sales¥4,966 million (YoY -8.0%)
Operating profit¥469 million (YoY -41.5%)
Ordinary income¥477 million (YoY -40.5%)
Profit attributable to owners of the parent¥326 million (YoY -44.8%)
Net income per share¥181.54
Equity ratioEnd of the current fiscal period 51.4 / End of previous period 49.6
Total assets¥5,741 million
Net assets¥2,975 million
Full-year earnings forecastNet Sales ¥6,550 million (YoY -7.9%) / Operating profit ¥550 million (YoY -38.9%) / Ordinary income ¥555 million (YoY -38.1%) / Net income ¥375 million (YoY -42.0%)
Revision to Earnings ForecastNot disclosed → Net Sales 6,550 / Operating profit 550 / Ordinary income 555 / Net income 375
Annual Dividend Forecast241 yen → 210 yen(-12.9%)
Segment revenueMedia Business 4,601,219 thousand yen (YoY -5.0%), Solutions Business 365,162 thousand yen (YoY -33.9%)
Segment profitMedia Business 485,029 thousand yen (YoY -30.7%), Solutions Business -15,798 thousand yen
Depreciation and amortization72,654 thousand yen
Breakdown of extraordinary income (loss)Current fiscal year No extraordinary gains or losses recorded
Disclosure regarding the going concern assumptionNo applicable matters
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No
Changes in the scope of consolidationNew 0 companies / Excluded 0 companies / Company name None
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingYes (for analysts and institutional investors)
Issued Shares at Period-End1,868,839 shares
Treasury Shares at Period-End81,032 shares
Factors Behind Changes in Business PerformanceLower web advertising rates, changes in traffic from search engines, and lower revenue due to intensifying competition in the medical aesthetics sector. In the Solutions business, the impact of large customers revising their contract terms and the increase in direct advertising placements by advertisers as the market matured. Recurring revenue in the industry-specific business increased 68.2% year on year.
Items this document does not state (11)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogImpairment lossMaterial subsequent events

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Revenue declined due to lower web advertising rates, changes in traffic from search engines, and intensifying competition in the medical aesthetics sector. In the Solutions business, the effects of market maturation also continued, including the impact of large customers revising their contract terms and the increase in direct advertising placements by advertisers. Meanwhile, recurring revenue in the industry-specific business increased 68.2% year on year, although a certain period is required before the effects of the measures implemented are reflected in results.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Summary of Financial Results for the Third Quarter of the Fiscal Year Ending December 2026 [Japanese GAAP] (Consolidated) | GMO Media,Inc. (6180) timely disclosure | Komori